[Beta-2 agonists].
Devillier
P
P
D000318:Adrenergic beta-Agonists / Q000737:chemistry / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000737:chemistry / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D002118:Calcium / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism; D019204:GTP-Binding Proteins / Q000235:genetics; D005938:Glucocorticoids / Q000494:pharmacology; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy; D008563:Membrane Lipids / Q000378:metabolism; D018727:Muscarinic Antagonists / Q000494:pharmacology; D009218:Myosins / Q000378:metabolism; D018343:Receptors, Adrenergic, beta-2 / Q000187:drug effects; D013237:Stereoisomerism; D013997:Time Factors
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D008563:Membrane Lipids; D018727:Muscarinic Antagonists; D018343:Receptors, Adrenergic, beta-2; D000242:Cyclic AMP; D019204:GTP-Binding Proteins; D009218:Myosins; D002118:Calcium